{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:47:29Z","timestamp":1782521249167,"version":"3.54.5"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"DOI":"10.7759\/cureus.111582","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:23:43Z","timestamp":1782519823000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk-Adapted Empiric Therapy for Acute Cholangitis: Beyond the Broad- Versus Narrow-Spectrum Dichotomy"],"prefix":"10.7759","author":[{"given":"Sakue","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makomo","family":"Makazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0346452","article-title":"Clinical impact of broad- versus narrow-spectrum empiric therapy in acute cholangitis: a Japanese claims database study","volume":"21","author":"Aoto K","year":"2026","unstructured":"Aoto K, Inose R, Muraki Y. Clinical impact of broad- versus narrow-spectrum empiric therapy in acute cholangitis: a Japanese claims database study. PLoS One. 2026, 21:e0346452. 10.1371\/journal.pone.0346452","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.518","article-title":"Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis","volume":"25","author":"Gomi H","year":"2018","unstructured":"Gomi H, Solomkin JS, Schlossberg D, et al.. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018, 25:3-16. 10.1002\/jhbp.518","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/a-2230-8229","article-title":"Association of short-course antimicrobial therapy and bacterial resistance in acute cholangitis: retrospective cohort study","volume":"12","author":"Masuda S","year":"2024","unstructured":"Masuda S, Jinushi R, Imamura Y, et al.. Association of short-course antimicrobial therapy and bacterial resistance in acute cholangitis: retrospective cohort study. Endosc Int Open. 2024, 12:E307-16. 10.1055\/a-2230-8229","journal-title":"Endosc Int Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169900","article-title":"Risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis","volume":"12","author":"Reuken PA","year":"2017","unstructured":"Reuken PA, Torres D, Baier M, et al.. Risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis. PLoS One. 2017, 12:e0169900. 10.1371\/journal.pone.0169900","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.12087","article-title":"Navigating antibiotic therapy in acute cholangitis: best practices and new insights","volume":"32","author":"Masuda S","year":"2025","unstructured":"Masuda S, Imamura Y, Jinushi R, Kimura K, Ryozawa S, Koizumi K. Navigating antibiotic therapy in acute cholangitis: best practices and new insights. J Hepatobiliary Pancreat Sci. 2025, 32:44-57. 10.1002\/jhbp.12087","journal-title":"J Hepatobiliary Pancreat Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/507347-risk-adapted-empiric-therapy-for-acute-cholangitis-beyond-the-broad--versus-narrow-spectrum-dichotomy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:23:43Z","timestamp":1782519823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/507347-risk-adapted-empiric-therapy-for-acute-cholangitis-beyond-the-broad--versus-narrow-spectrum-dichotomy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.111582","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}